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ABSTRACT
Background. Microalbuminuria is common in the general
adult population, with a prevalence of ∼7%, and is an inde-
pendent indicator of renal and cardiovascular risks. Whether
albuminuria is acquired during life (as a result of hyperten-
sion/diabetes) or is congenital and already present at birth is
unknown. We studied the prevalence of microalbuminuria in
toddlers and compared the distribution of albuminuria with
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for possible associations between microalbuminuria and ante-
natal, postnatal and maternal factors.
Methods. The urinary albumin concentration (UAC) was mea-
sured in 1352 children and the urinary albumin:creatinine
ratio (UACR) in 1288 children from the Groningen Expert Cen-
ter for Kids with Obesity (GECKO) Drenthe cohort (age range
20–40 months). Albuminuria distribution was compared with
the albuminuria distribution in 40 854 participants of the gen-
eral adult cohort of the Prevention of Renal and Vascular End
stage Disease (PREVEND) study. Associations between albu-
minuria (expressed as UAC and UACR) and antenatal, postnatal
and maternal factors were tested with linear regression analysis.
Results. The median UAC in the GECKO study was 2.3 mg/L
(5th–95th percentiles: 2.1–25.5) and in the PREVEND study it
was 6.0 mg/L (2.3–28.6) (P distribution comparison 0.053). The
prevalence of UAC≥ 20 mg/L was 6.9% in the GECKO study
and 7.8% in the PREVEND study (P = 0.195). The prevalence of
UACR≥ 30 mg/g in the GECKO study was 23.4%. UAC and UACR
were lower in boys. UAC was not associated with other determi-
nants, but UACR was associated with age and gestational diabetes.
Conclusions. The distribution of UAC and the prevalence of
UAC > 20 mg/L in toddlers and in the young general adult
population are comparable. These ﬁndings suggest that micro-
albuminuria is a congenital condition that may predispose to a
higher cardiovascular risk later in life.
Keywords: albuminuria, cardiovascular risk, children, epi-
demiology, microalbuminuria
INTRODUCTION
A mild to moderate increase of urinary albumin has a high
prevalence in patients with diabetes mellitus, hypertension
and chronic kidney disease [1, 2]. This so-called microalbumi-
nuria appears to be a risk marker for renal and cardiovascular
diseases later in life [3, 4].
It has been discussed whether these increased albuminuria
levels are a consequence of renal disease or if albuminuria itself
is an independent risk factor for renal and/or cardiovascular
disease. Interesting in this context is the ﬁnding that apparently
‘healthy’ individuals without renal disease, diabetes or hyper-
tension also show a high prevalence of microalbuminuria, vary-
ing from 5.5 to 6.6%. Microalbuminuria is also a predictor for
future cardiovascular events [5–8]. These ﬁndings appear to
support the suggestion that microalbuminuria is an independ-
ent risk factor—and could maybe even be a cause—of renal and
cardiovascular diseases.
The putative mechanism of such a causal relationship be-
tween excessive albumin leak and renal/cardiovascular disease
could be an endothelial dysfunction, such as glycocalyx loss [9].
This dysfunction ‘allows’ albumin to escape the vascular space
and induces subendothelial vascular low-grade inﬂammation,
with the ultimate consequence of widespread organ damage
[10]. The cause of this endothelial dysfunction—and thus of
themicroalbuminuria—is unknown, but it might be congenital,
meaning that different individuals are born with a large variabil-
ity in vascular function and therefore varying constitutional
urine albumin excretions. Indeed, increased albumin excretion
is observed in newborns and toddlers in small studies measuring
laboratory reference values [11]. This observation is supported
by experimental studies demonstrating a large variability in
endothelial function in rats at birth. These data also show that
the rats with the poorest endothelial function were the most sus-
ceptible to renal damage [12]. This could imply that some indi-
viduals have already at birth high levels of albuminuria, as a result
of inborn impaired endothelial function, which in the long term
leads to a higher renal and cardiovascular risk [13].
The aim of the current study was to describe the distribution
of albuminuria and the prevalence of microalbuminuria in very
young children. Furthermore, we intended to identify antenatal,
postnatal and maternal factors that could explain differences
between children. For this purpose, we investigated a large co-
hort of toddlers of the general Dutch population [Groningen
Expert Center for Kids with Obesity; (GECKO)]. These data
were compared with the data from the general adult Dutch
population of the Prevention of Renal and Vascular End stage
Disease (PREVEND) cohort.
MATERIALS AND METHODS
This study was embedded in the GECKO Drenthe study, a
population-based prospective birth cohort study of children
born between April 2006 and April 2007 in Drenthe, a northern
Dutch province. The primary goal of this cohort was to inves-
tigate overweight risk factors from birth throughout childhood.
Details about this cohort have been previously described and
are registered at www.birthcohorts.net [14]. The study was ap-
proved by the local Medical Research and Ethics Committee.
All mothers signed an informed consent form.
In the recruitment period between April 2006 and April
2007, 4778 eligible children were born. Of them, 2874 par-
ent–child pairs have ever participated actively in the cohort.
At birth, the obstetricians, midwives or general practitioners
took an umbilical cord blood sample that was processed and
stored for future analysis. In addition, placenta weight was mea-
sured and data on pregnancy and delivery (i.e. gestational dia-
betes, gestational hypertension, smoking of the mother,
maternal age at delivery) were recorded. The study design in-
cluded anthropometric measurements (including weight,
height and head, waist and hip circumference) performed by
speciﬁcally trained nurses at municipal health services at the
ages of 0.5, 1, 2, 3, 4, 5, 6, 7, 9, 11, 14, 18, 24, 36, 45 and 60
months. Questionnaires about lifestyle and environment (in-
cluding maternal education level) were ﬁlled in by parents in
the last trimester of pregnancy and at each health control visit.
The 24-month visit was complemented by ameasurement of
arterial blood pressure and urine collection. For the present
analyses, exclusion was based on the availability of a urine sam-
ple with albumin measurement. A urinary albumin measure-
ment was obtained in 1352 children.
Blood pressure measurement
Blood pressuremeasurement was performed on the left arm in
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Johnson, New Brunswick, NJ, USA). Blood pressure measure-
ment was repeated if the child remained comfortable during the
procedure or if the ﬁrst measurement was unsuccessful.
Urine collection and measurements
Urine collection in toddlers is known to be cumbersome,
and urine cannot be extracted from disposable diapers. The
currently available plastic bags for urine collection tend to de-
tach easily from children’s skin. We therefore designed and va-
lidated a speciﬁc protocol for urine collection at the Clinical
Pharmacology Department of the University Medical Center
Groningen (UMCG) using pantyliners. We chose a pantyliner
with a simple cottonwool ﬁlling, because pilot tests showed that
extracting the urine from these pantyliners was easy and con-
venient for parents and children. Parents received during the
24-month health control visit a kit with a pantyliner (Kruidvat
Femme Care mini®, Kruidvat, The Netherlands), a plastic vial
and safety bag (both from Minigrip, Lelystad, The Nether-
lands), a collection form and a postal plastic envelope for bio-
logical materials. Parents were asked to place the pantyliner in
the child’s diaper and remove it once the child had voided. They
were also asked to write down the time of placement and re-
moval of the pantyliner. Parents were instructed to discard pan-
tyliners in case of faecal contamination and to repeat the
operation later in time. Pantyliners with properly collected
urine were placed by parents in the plastic vial and sent as
soon as possible by regular mail to the hospital using a dedi-
cated envelope for biological materials. Parents were also
asked to include a collection form stating the collection date,
child’s study number and possible concurrent diseases. Directly
upon arrival at the laboratory, the cotton ﬁlling of the pantyli-
ners was extracted and centrifuged at 3600 rpm for 10 min
(Mistral 3000, MSE). UAC was measured in the centrifuged
urine by nephelometry (Behring Nephelometer Analyzer II,
Siemens Medical Solutions), with a threshold of 2.1 mg/L. Va-
lues of UAC below the detection limit were assigned the value of
2.1 mg/L. Urinary creatinine concentration (Ucc) was measured
by the enzymatic method (Roche Modular), with a threshold of
0.1 mmol/L.
Performance of the method against standard urine collec-
tion for albumin measurement was analysed as proposed by
Stevens [15], presenting bias, precision and accuracy. Bias was
deﬁned as themedian difference between standard urine collec-
tion and the pantyliner method, precision as the interquartile
range of the difference between the standard method and panty-
liner method and accuracy as the percentage of estimates of the
pantylinermethodwithin 30%of the value of the standardmeth-
od. Bias of themethod was−14.0 mg/L, precision 31.3 mg/L and
accuracy 48.1%.
Adult cohort
The PREVENDstudy protocol has been extensively described
elsewhere and can be found at www.prevend.org [5]. In short, in
the period between 1997 and 1998, all inhabitants of the city of
Groningen (in the northern part of TheNetherlands) ages 28–75
years (n = 85421) were invited to answer a short questionnaire
regarding demographics and risk factors for renal and cardiovas-
cular diseases and to collect aﬁrst morning void urine sample for
albumin concentration measurement. A total of 40 854 indivi-
duals (48%) gave written informed consent and were included
in the PREVEND cohort. The characteristics of the 40 854 PRE-
VEND study participants are shown in Supplementary data,
Table S1.
Statistical analysis
Descriptive characteristics of the study population were re-
ported as mean ± standard deviation or median (25th–75th
percentile), as required. The distributions of UAC between the
toddler and adult population were compared with the Brown
and Forsythemodiﬁed Levene’s robust statistics test. Since urin-
ary creatinine was not measured in the PREVEND cohort, only
comparison of UAC was possible between the two cohorts. The
difference in prevalence of increased albuminuria (UAC ≥ 20
mg/L) between the GECKO and PREVEND studies was tested
with a χ2 test. Possible associations between antenatal, postnatal
andmaternal factors and the logarithmofUACwere analysedwith
univariate linear regression analysis. UAC was log-transformed to
account for its skewed distribution. A P-value < 0.05 was consid-
ered to be statistically signiﬁcant. Data were analysed using
STATA version 13.1 and SPSS Statistics version 22.
RESULTS
Of the 1352 children included in this study (Figure 1), measure-
ments of Ucc were available in 1288 children. Data for body
mass index (BMI) were available in 1017 children, blood pres-
sure measurement in 817 children and placenta weight in 940
children. The characteristics of the study population are shown
in Table 1.
The distribution of UAC in the GECKO cohort is shown in
Figure 2A. The median UAC was 2.3 mg/L (25th–75th percent-
ile interval 2.1–7.1 mg/L). The 5th and 95th percentiles were,
respectively, 2.1 and 25.5 mg/L. The median UACR was 14.0
mg/g (25th–75th percentile interval 8.0–25.6 mg/g). The 5th
and 95th percentiles were, respectively, 4.3 and 89.3 mg/g.
The prevalence of elevated albuminuria based on UAC ( ≥20
mg/L) and UACR (≥30 mg/g) was, respectively, 6.9 and 23.4%.
The distribution of UAC in the PREVEND population (n =
40854) is shown in Figure 2B. The median UAC was 6.0 mg/L
(25th–75th percentile interval 3.7–9.8 mg/L). The 5th and
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95th percentiles were, respectively, 2.3 and 28.6 mg/L. The
prevalence of elevated UAC was 7.8%. The distribution of UAC
in the GECKO and PREVENDpopulation did not differ signiﬁ-
cantly (Figure 2; P = 0.053), as did the prevalence of elevated
albuminuria (Figure 3; P = 0.195).
The prevalence of elevated albuminuria in the PREVEND
study depended on age (the older, themoremicroalbuminuria).
Therefore, we plotted the percentage of increased albuminuria
of the GECKO study combined with the PREVEND study ac-
cording to age (Figure 4). Although there is a large age gap be-
tween the two cohorts, it seems that the GECKOdata are similar
to those of the young adult population of PREVEND. The
prevalence of increased albuminuria in the PREVEND popula-
tion <50 years of age was 5.8 versus 6.9% in GECKO (P = 0.09).
We tested the hypothesis of possible associations between
UAC or UACR in the GECKO cohort and antenatal, postnatal
and maternal factors. UAC and UACR were negatively associated
with male gender (P < 0.001). No association was found
F IGURE 2 : Distribution curves of UAC in (A) GECKO and (B) PREVEND.








25.8 (24.8–27.1) 25.8 (24.8–27.1)
Male, n (%) 683 (50.5) 655 (50.9)
UAC, mg/L (25th–75th
percentile)
2.3 (2.1–7.1) 2.4 (2.1–7.1)
Body weight, kg (SD) 13.2 (1.5) 13.2 (1.5)
BMI, kg/m2 (SD) 16.3 (1.3) 16.3 (1.3)
Systolic BP, mmHg (SD) 101.1 (12.5) 101.2 (12.6)
Diastolic BP, mmHg (SD) 60.5 (11.5) 60.5 (11.6)
Pregnancy, birth and maternal characteristics
Gestational age at birth,
weeks (SD)
39.8 (1.6) 39.8 (1.6)
Birthweight, g (SD) 3550.8 (565.9) 3553 (563)
Placenta weight, g (SD) 654.4 (153.8) 650 (149)
Maternal age at delivery,
years (SD)
30.9 (4.3) 30.9 (4.25)
Gestational diabetes, n (%) 47 (3.5) 43 (3.36)
Gestational hypertension, n (%) 146 (10.9) 140 (10.92)
Smoking during pregnancy,
n (%)
164 (12.3) 155 (12.20)
Maternal education level
(university), n (%)
497 (38.0) 478 (38.24)
Values for continuous variables are described as mean ± standard deviation or median
(25th–75th percentile), as required; values for categorical variables as number
(percentage).
UAC, urinary albumin concentration; UACR, urinary albumin-to-creatinine ratio; BP, blood
pressure; BMI, body mass index.
F IGURE 3 : Prevalence of different levels of urinary albumin con-
centration (UAC) in the general toddler population (GECKO) when
compared with the general adult population (PREVEND) in the nor-
thern Dutch provinces.
F IGURE 4 : Prevalence of increased albuminuria (UAC≥ 20 mg/L) in
different age ranges in the general population of the Dutch northern
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between UAC and other antenatal, postnatal or maternal factors.
UACR was associated with age and gestational diabetes (Table 2).
DISCUSSION
This study provides unique information about the natural dis-
tribution of albuminuria in the general toddler population. The
most interesting ﬁnding is the wide range of albuminuria in
young children. This shows how in toddlers, just as in the gen-
eral adult population of the same geographic region, there is an
important variability in albumin excretion. Moreover, when
comparing the prevalence of UAC ≥ 20 mg/L in the young
adult and toddler cohorts, these are strikingly similar, increas-
ing in time as individuals get older. To our knowledge, this is
the ﬁrst time that urine albumin levels have been studied on
an epidemiological scale in toddlers.
What is the meaning of these increased levels of urinary
albumin already in such young individuals? And what is the
meaning of the striking similarity of the prevalence of microal-
buminuria in the toddler and adult population? If increased le-
vels of albumin in the urine are a consequence of renal damage,
these children must have been damaged just after birth or in
utero. This could ﬁt with the so-called Barker hypothesis in
which ‘external’ inﬂuences determine the intra-uterine devel-
opment of the foetus, causing diseases later in life [16]. We
selected a number of variables that, according to the Barker hy-
pothesis, could have had a relationship with microalbuminuria.
Some associations have been previously reported [17, 18]. In
our study, we could not ﬁnd an association with factors such
as birthweight or placenta weight, as we would have expected
on the basis of the Barker hypothesis. The only association
found was between UACR and gestational diabetes and between
UACR and age. It could be that albuminuria at the paediatric age
is mostly affected by genetic factors and predisposition and not
by (or less by) environmental or pregnancy factors. This does
not exclude that these factors could have a stronger inﬂuence
on renal outcome later in life. Nevertheless, the lack of associa-
tions between albuminuria and birthweight, gestational age,
impaired placental growth, gestational hypertension and smok-
ing during pregnancy does not support the Barker hypothesis as
a mechanism for the development of increased albuminuria in
toddlers.
An alternative hypothesis would be that children are born
with a constitutive different albuminuria excretion (natural
variation). It is well possible that children are born with a var-
iety of vascular function (endothelial function) and that this is
reﬂected by a varying degree of albumin leakage in all vessels
including the kidney [13]. When urinary albumin concentra-
tion is plotted against age in the adult population, it becomes
clear that urinary albumin concentration varies between indivi-
duals at all ages (Figure 5) [5, 19]. Intriguingly, when the indi-
vidual variation of albuminuria in toddlers and children is
compared with the adult population [11], a strikingly similar
pattern is observed with nearly similar median and 95th
Table 2. Association of UAC and UACR with prenatal, post-natal and maternal factors
UAC UACR
Coefﬁcient (95% CI) P-value Coefﬁcient (95% CI) P-value
Toddler characteristics
Age, months −0.02 (−0.04–0.01) 0.119 −0.04 (−0.07–0.01) 0.003
Male gender −0.20 (0.11–0.30) <0.001 −0.13 (0.03–0.24) 0.010
BMI, kg/m2 0.03 (−0.01–0.07) 0.158 0.04 (−0.00–0.01) 0.063
Systolic BP, mmHg 0.00 (0.00–0.01) 0.687 0.00 (−0.01–0.01) 0.914
Diastolic BP, mmHg 0.00 (−0.01–0.01) 0.926 −0.00 (0.01–0.00) 0.585
Pregnancy, birth and maternal characteristics
Gestational age at birth, weeks −0.00 (−0.03–0.03) 0.903 −0.01 (−0.04–0.02) 0.586
Birthweight, g 0.00 (−0.00–0.00) 0.994 0.00 (−0.00–0.00) 0.203
Placenta weight, g −0.00 (−0.00–0.00) 0.488 0.00 (−0.00–0.00) 0.948
Maternal age at delivery, years −0.00 (−0.01–0.01) 0.615 −0.00 (−0.01–0.00) 0.899
Gestational diabetes 0.18 (−0.08–0.44) 0.165 0.34 (0.06–0.63) 0.019
Gestational hypertension −0.05 (−0.20–0.10) 0.532 −0.11 (−0.27–0.06) 0.202
Smoking during pregnancy (yes versus no) −0.11 (−0.26–0.03) 0.123 0.02 (−0.14–0.18) 0.821
Maternal university (yes versus no) −0.02 (−0.12–0.08) 0.727 −0.03 (−0.14–0.08) 0.612
Univariate linear regression on logUAC and logUACR.
UAC, urinary albumin concentration; UACR, urinary albumin-to-creatinine ratio; CI, conﬁdence interval; BP, blood pressure; BMI, body mass index.
F IGURE 5 : Individual variation of urinary albumin concentration is
relatively constant with ageing. Median and 97.5th percentile of the
UAC distribution according to different age categories in two adult
general population cohorts (PREVEND and NHANES), a child cohort
(Lehrnbecher) and a toddler cohort (GECKO). *95th percentile of UAC
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percentiles of the urinary albumin concentration from young
age to adolescence. These ﬁndings suggest that an individual
is born with a certain albuminuria level that remains (relatively)
constant for that individual over time and may represent a vas-
cular state that is associated with a risk for organ damage. These
ﬁndings make the alternative hypothesis that high urinary albu-
min excretion in toddlers is an expression of vasculature devel-
opment early in life and increased albuminuria diminishes
during development less likely. Longitudinal studies with mul-
tiple albuminuria measurements during life are obviously ne-
cessary to conﬁrm or refute this hypothesis.
Most adult studies use a creatinine-corrected urinary albu-
min concentration as the optimal representation for describing
the amount of albumin leakage [7, 20]. The use of creatinine is
meant to correct albumin for urine concentration and dilution
differences, and indeed works well in adults [21]. A striking
ﬁnding of our study is that, according to the UACR cut-off points
used in the adult population (i.e. UACR≥ 30 mg/g), 23.4% of the
toddlers were found to have high urinary albumin. This ex-
tremely high prevalence might be driven by the low urinary cre-
atinine values in toddlers, which reﬂects the lower muscle mass
when compared with older children and adults. Although UACR
is a useful measurement also in toddlers, we believe that the cut-
off points used for adults are not appropriate for young children
and we suggest that the 95th percentile should be used. In the
study by Sanchez-Bayle et al. [22], a similar median UACR was
found in children <6 years of age, but our cohort shows a wider
distribution. We speculate that this might be related to a differ-
ent genetic background of the populations or to differences in
environmental factors.
A certainly interesting ﬁnding in our cohort is the gender
difference in albuminuria, both if expressed as UAC or UACR.
Male gender had a statistically signiﬁcant negative association
with albuminuria, meaning that female toddlers have a higher
urinary albumin concentration when compared with males. In
studies on general adult populations, a higher male prevalence
of albuminuria has mostly been found. In paediatric studies,
data are non-consistent [22, 23]. Nevertheless, a higher preva-
lence of high urinary albuminuria has been found also in
the National Health and Nutrition Examination Survey
(NHANES) [19]. Albuminuria in this survey was expressed as
UACR, and the children of this survey were older (6–19 years), so
the differences were interpreted as differences in muscle mass.
This explanation cannot be applied to our cohort, as Ucc did not
differ per gender. We cannot exclude that this ﬁnding in our
cohort is only due to chance and this needs to be conﬁrmed
or refuted in repeated studies.
Probably because of difﬁculties in urine collection in tod-
dlers and young children, most previous paediatric studies
have investigated urinary albumin in school-aged children or
adolescents [22–25]. Data concerning albuminuria in toddlers
are limited to small numbers of individuals [11]. To our knowl-
edge, this is the ﬁrst study investigating albuminuria in a large
toddler cohort. Many of the previous studies on albuminuria
in children report daily urinary albumin excretion, UACR or
UAC in spot urine, but not microalbuminuria prevalence.
Unfortunately, this hampers direct comparison with our data.
In addition, to our knowledge, this is the ﬁrst study that directly
compared the prevalence of microalbuminuria in a toddler
population with the adult population of the same geographical
region.
Our study has several limitations. TheUACmeasurement was
done on a single sample. Thus we have no information on
whether the albuminuria values in these children are constant
in time or could be inﬂuenced by concurrent problems such
as viral infections or timing of the sampling (morning versus
afternoon), andwe do not know if these values are representative
of the daily urinary albumin excretion. However, we made the
comparison with an adult population also using single urine
samples to determine the prevalence of microalbuminuria.
Second, the urine collection method used has a rather poor re-
covery. It is possible that the albumin is retained in the cotton
wool of the pantyliners in some individuals, leading to albumin
concentrations below the detection limit. This bias, however,
does not have a big impact on our conclusion since it only
leads to an underestimation of the UAC measurements in the
toddlers.
In conclusion, urinary albumin excretion in toddlers is very
similar to that in young adults, including the prevalence of mi-
croalbuminuria. This ﬁnding has important implications for
the current pathophysiological view on albuminuria as a
cause or consequence of renal and cardiovascular disease.
Our data suggest that albumin excretion may represent an in-
born constitutive characteristic, determining the fate of the in-
dividual in later life.
FUNDING
The GECKODrenthe birth cohort was funded by an unrestrict-
ed grant of HutchisonWhampoa Ltd, Hong Kong and received
support from the UMCG.
SUPPLEMENTARY MATERIAL
Supplementary data are available online at http://ndt.oxford
journals.org.
ACKNOWLEDGEMENTS
We thank all parents and children for participation in the
GECKO Drenthe cohort, Prof. S.J.L. Bakker for his support in
designing urine collections and Dr Kröpelin for statistical
advice and support.
CONFLICT OF INTEREST STATEMENT
D.d.Z. is a consultant for and receives honoraria (to employer)
from AbbVie, Astellas, ChemoCentryx, Eli Lilly, Janssen, Frese-
nius and Merck Darmstadt. H.J.L.H. received a research grant
from AstraZeneca (payment to employer) and is a consultant
for and receives honoraria (to employer) from AbbVie, Astellas,













P r e v a l e n c e a n d d i s t r i b u t i o n o f ( m i c r o ) a l b u m i n u r i a i n t o d d l e r s 1691Downloaded from https://academic.oup.com/ndt/article-abstract/31/10/1686/2222574
by University of Groningen user
on 08 December 2017
REFERENCES
1. Keen H, Chlouverakis C, Fuller J et al. The concomitants of raised blood
sugar: studies in newly-detected hyperglycaemics: II. Urinary albumin ex-
cretion, blood pressure and their relation to blood sugar levels. Int J Epide-
miol 2014; 43: 11–15
2. Wachtell K, Palmieri V, Olsen MH et al. Urine albumin/creatinine ratio
and echocardiographic left ventricular structure and function in hypertensive
patients with electrocardiographic left ventricular hypertrophy: the LIFE
study. Losartan intervention for endpoint reduction. Am Heart J 2002; 143:
319–326
3. Ninomiya T, Perkovic V, de Galan BE et al. Albuminuria and kidney func-
tion independently predict cardiovascular and renal outcomes in diabetes. J
Am Soc Nephrol 2009; 20: 1813–1821
4. van der Velde M, Halbesma N, de Charro FT et al. Screening for albumin-
uria identiﬁes individuals at increased renal risk. J Am Soc Nephrol 2009; 20:
852–862
5. Hillege HL, JanssenWM, Bak AA et al. Microalbuminuria is common, also
in a nondiabetic, nonhypertensive population, and an independent indica-
tor of cardiovascular risk factors and cardiovascular morbidity. J Intern
Med 2001; 249: 519–526
6. Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts
cardiovascular and noncardiovascular mortality in general population. Cir-
culation 2002; 106: 1777–1782
7. Romundstad S, Holmen J, Kvenild K et al. Microalbuminuria and all-cause
mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up
study. The Nord-Trondelag health study (HUNT), Norway. Am J Kidney
Dis 2003; 42: 466–473
8. Arnlov J, Evans JC, Meigs JB et al. Low-grade albuminuria and incidence
of cardiovascular disease events in nonhypertensive and nondiabetic
individuals: the Framingham heart study. Circulation 2005; 112:
969–975
9. Salmon AH, Ferguson JK, Burford JL et al. Loss of the endothelial glycoca-
lyx links albuminuria and vascular dysfunction. J Am Soc Nephrol 2012; 23:
1339–1350
10. Salmon AH, Satchell SC. Endothelial glycocalyx dysfunction in disease: al-
buminuria and increased microvascular permeability. J Pathol 2012; 226:
562–574
11. Lehrnbecher T, Greissinger S, Navid F et al. Albumin, IgG, retinol-binding
protein, and alpha1-microglobulin excretion in childhood. Pediatr Nephrol
1998; 12: 290–292
12. Gschwend S, Buikema H, Navis G et al. Endothelial dilatory function pre-
dicts individual susceptibility to renal damage in the 5/6 nephrectomized
rat. J Am Soc Nephrol 2002; 13: 2909–2915
13. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early
marker for cardiovascular disease. J Am Soc Nephrol 2006; 17: 2100–2105
14. L’Abee C, Sauer PJ, Damen M et al. Cohort proﬁle: the GECKO Drenthe
study, overweight programming during early childhood. Int J Epidemiol
2008; 37: 486–489
15. Stevens LA, Zhang Y, Schmid CH. Evaluating the performance of equations
for estimating glomerular ﬁltration rate. J Nephrol 2008; 21: 797–807
16. Barker DJ. The fetal and infant origins of adult disease. BMJ 1990; 301: 1111
17. Keijzer-Veen MG, Schrevel M, Finken MJ et al. Microalbuminuria and
lower glomerular ﬁltration rate at young adult age in subjects born very pre-
mature and after intrauterine growth retardation. J Am Soc Nephrol 2005;
16: 2762–2768
18. Keijzer-Veen MG, Kleinveld HA, Lequin MH et al. Renal function and size
at young adult age after intrauterine growth restriction and very premature
birth. Am J Kidney Dis 2007; 50: 542–551
19. Jones CA, Francis ME, Eberhardt MS et al. Microalbuminuria in the US
population: third national health and nutrition examination survey. Am J
Kidney Dis 2002; 39: 445–459
20. YuyunMF, Khaw KT, Luben R et al. Microalbuminuria independently pre-
dicts all-cause and cardiovascular mortality in a British population: the
European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk)
population study. Int J Epidemiol 2004; 33: 189–198
21. Bakker AJ. Detection ofmicroalbuminuria. receiver operating characteristic
curve analysis favors albumin-to-creatinine ratio over albumin concentra-
tion. Diabetes Care 1999; 22: 307–313
22. Sanchez-Bayle M, Rodriguez-Cimadevilla C, Asensio C et al. Urinary albu-
min excretion in Spanish children.Nino Jesus Group. Pediatr Nephrol 1995;
9: 428–430
23. Tsiouﬁs C,Mazaraki A, Dimitriadis K et al. Microalbuminuria in the paedi-
atric age: current knowledge and emerging questions. Acta Paediatr 2011;
100: 1180–1184
24. Rademacher ER, Sinaiko AR. Albuminuria in children. Curr Opin Nephrol
Hypertens 2009; 18: 246–251
25. Rademacher E, MauerM, Jacobs DR Jr et al. Albumin excretion rate in nor-
mal adolescents: relation to insulin resistance and cardiovascular risk fac-
tors and comparisons to type 1 diabetes mellitus patients. Clin J Am Soc
Nephrol 2008; 3: 998–1005













1692 V. Gracchi et al.Downloaded from https://academic.oup.com/ndt/article-abstract/31/10/1686/2222574
by University of Groningen user
on 08 December 2017
